260 related articles for article (PubMed ID: 26944411)
1. Local iron homeostasis in the breast ductal carcinoma microenvironment.
Marques O; Porto G; Rêma A; Faria F; Cruz Paula A; Gomez-Lazaro M; Silva P; Martins da Silva B; Lopes C
BMC Cancer; 2016 Mar; 16():187. PubMed ID: 26944411
[TBL] [Abstract][Full Text] [Related]
2. Regulating ferroportin-1 and transferrin receptor-1 expression: A novel function of hydrogen sulfide.
Zhang MW; Yang G; Zhou YF; Qian C; Mu MD; Ke Y; Qian ZM
J Cell Physiol; 2019 Apr; 234(4):3158-3169. PubMed ID: 30370692
[TBL] [Abstract][Full Text] [Related]
3. Effects of aspirin on expression of iron transport and storage proteins in BV-2 microglial cells.
Xu YX; Du F; Jiang LR; Gong J; Zhou YF; Luo QQ; Qian ZM; Ke Y
Neurochem Int; 2015 Dec; 91():72-7. PubMed ID: 26522688
[TBL] [Abstract][Full Text] [Related]
4. Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load.
Fillebeen C; Charlebois E; Wagner J; Katsarou A; Mui J; Vali H; Garcia-Santos D; Ponka P; Presley J; Pantopoulos K
Blood; 2019 Jan; 133(4):344-355. PubMed ID: 30538134
[TBL] [Abstract][Full Text] [Related]
5. The iron regulatory hormone hepcidin inhibits expression of iron release as well as iron uptake proteins in J774 cells.
Du F; Qian ZM; Gong Q; Zhu ZJ; Lu L; Ke Y
J Nutr Biochem; 2012 Dec; 23(12):1694-700. PubMed ID: 22560353
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats.
Du F; Qian ZM; Luo Q; Yung WH; Ke Y
Mol Neurobiol; 2015 Aug; 52(1):101-14. PubMed ID: 25115800
[TBL] [Abstract][Full Text] [Related]
8. Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors.
Pizzamiglio S; De Bortoli M; Taverna E; Signore M; Veneroni S; Cho WC; Orlandi R; Verderio P; Bongarzone I
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216608
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin regulates intrarenal iron handling at the distal nephron.
Moulouel B; Houamel D; Delaby C; Tchernitchko D; Vaulont S; Letteron P; Thibaudeau O; Puy H; Gouya L; Beaumont C; Karim Z
Kidney Int; 2013 Oct; 84(4):756-66. PubMed ID: 23615502
[TBL] [Abstract][Full Text] [Related]
10. Disordered hepcidin-ferroportin signaling promotes breast cancer growth.
Zhang S; Chen Y; Guo W; Yuan L; Zhang D; Xu Y; Nemeth E; Ganz T; Liu S
Cell Signal; 2014 Nov; 26(11):2539-50. PubMed ID: 25093806
[TBL] [Abstract][Full Text] [Related]
11. Both iron excess and iron depletion impair viability of rat H9C2 cardiomyocytes and L6G8C5 myocytes.
Kasztura M; Dzięgała M; Kobak K; Bania J; Mazur G; Banasiak W; Ponikowski P; Jankowska EA
Kardiol Pol; 2017; 75(3):267-275. PubMed ID: 27747853
[TBL] [Abstract][Full Text] [Related]
12. Normal systemic iron homeostasis in mice with macrophage-specific deletion of transferrin receptor 2.
Rishi G; Secondes ES; Wallace DF; Subramaniam VN
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(3):G171-80. PubMed ID: 26608187
[TBL] [Abstract][Full Text] [Related]
13. Expression of programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase (IDO) in the tumor microenvironment and in tumor-draining lymph nodes of breast cancer.
Ye Q; Wang C; Xian J; Zhang M; Cao Y; Cao Y
Hum Pathol; 2018 May; 75():81-90. PubMed ID: 29447919
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
[TBL] [Abstract][Full Text] [Related]
15. Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of the breast: correlation with prognosis and the cancer-stromal interaction.
Morikawa A; Takeuchi T; Kito Y; Saigo C; Sakuratani T; Futamura M; Yoshida K
PLoS One; 2015; 10(5):e0125762. PubMed ID: 25955408
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin secretion was not directly proportional to intracellular iron-loading in recombinant-TfR1 HepG2 cells: short communication.
Mehta KJ; Busbridge M; Patel VB; Farnaud SJ
Mol Cell Biochem; 2020 May; 468(1-2):121-128. PubMed ID: 32185675
[TBL] [Abstract][Full Text] [Related]
17. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C
Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of hepcidin response to holotransferrin treatment in CHO TRVb-1 cells.
Mehta K; Greenwell P; Renshaw D; Busbridge M; Garcia M; Farnaud S; Patel VB
Blood Cells Mol Dis; 2015 Aug; 55(2):110-8. PubMed ID: 26142326
[TBL] [Abstract][Full Text] [Related]
19. Molecular regulation of cellular iron balance.
Recalcati S; Gammella E; Buratti P; Cairo G
IUBMB Life; 2017 Jun; 69(6):389-398. PubMed ID: 28480557
[TBL] [Abstract][Full Text] [Related]
20. Copper chelation and interleukin-6 proinflammatory cytokine effects on expression of different proteins involved in iron metabolism in HepG2 cell line.
Di Bella LM; Alampi R; Biundo F; Toscano G; Felice MR
BMC Biochem; 2017 Jan; 18(1):1. PubMed ID: 28118841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
